| Literature DB >> 34594121 |
Hui Luan1, Yan Song2, Lifei Cao1, Ping Wang1, Danjun Zhu1, Gang Tian1.
Abstract
PURPOSE: The study explored the association of waist circumference (WC) with the severity of cardiovascular diseases and hospital readmission of coronary artery disease (CAD) patients with normal body mass index (BMI). PATIENTS AND METHODS: 213 female and 431 male normal-BMI CAD patients were enrolled and assigned in three groups based on their gender-specific WC tertiles. Their cardiovascular risk factors and coronary angiography characteristics were analyzed in a cross-sectional study, and the gender-specific relationship between WC and one-year re-admission rate was prospectively explored.Entities:
Keywords: coronary artery disease; normal body mass index; one-year re-admission with adverse cardiovascular event; severe CAD; waist circumference
Year: 2021 PMID: 34594121 PMCID: PMC8477460 DOI: 10.2147/DMSO.S330194
Source DB: PubMed Journal: Diabetes Metab Syndr Obes ISSN: 1178-7007 Impact factor: 3.168
Baseline Characteristics and Angiographic Characteristics in Male and Female Subjects
| Characteristic | Whole Group (n=644) | Men (n=431) | Women (n=213) |
|---|---|---|---|
| Age (years) | 61.7 ± 9.13 | 60.8 ± 9.26 | 63.6 ± 8.60 |
| Height (cm) | 167.6 ± 7.95 | 171.6 ± 5.56 | 159.4 ± 5.43 |
| Weight (kg) | 64.02 ± 7.62 | 67.24 ± 6.32 | 57.50 ± 5.58 |
| Body mass index (kg/m2) | 23.4 (22.0–23.8) | 23.4 (22.2–23.8) | 23.3 (21.8–23.7) |
| Waist circumference (cm) | 88.3 (83.0–92.5) | 89.5 (85.0–94.0) | 84.5 (79.5–89.0) |
| Hip circumference (cm) | 92.5 (89.0–96.0) | 92.0 (88.0–95.0) | 94.0 (91.0–97.3) |
| Waist–hip ratio | 0.95 (0.92–0.99) | 0.98 (0.94–1.01) | 0.92 (0.89–0.95) |
| Family history of CAD, % | 163 (25.3) | 94 (21.8) | 69 (32.4) |
| Ever smokers, % | 212 (32.9) | 212 (49.2) | 0 (0) |
| History of diabetes, % | 135 (20.9) | 82 (19.0) | 53 (24.9) |
| History of hypertension, % | 289 (44.9) | 189 (43.9) | 100 (46.9) |
| Systolic BP (mmHg) | 129 (117–144) | 128 (116–142) | 130 (118–146) |
| Diastolic BP (mmHg) | 78 (70–84) | 78 (71–84) | 77 (69–83) |
| Menopause status, % | 194 (30.1) | – | 194 (91.1) |
| Fasting plasma glucose, mmol/L | 6.02 (5.10–8.08) | 5.97 (5.06–7.73) | 6.13 (5.16–8.53) |
| Glycosylated hemoglobin, % | 5.7 (5.4–6.1) | 5.7 (5.4–6.1) | 5.8 (5.4–6.2) |
| Total cholesterol, mmol/L | 3.56 (3.07–4.21) | 3.45 (2.95–4.03) | 3.84 (3.36–4.50) |
| LDL-C, mmol/L | 1.97 (1.60–2.57) | 1.90 (1.53–3.43) | 2.14 (1.79–2.74) |
| HDL-C, mmol/L | 0.96 (0.82–1.14) | 0.93 (0.79–1.08) | 1.03 (0.87–1.21) |
| Triglycerides, mmol/L | 1.31 (0.94–1.83) | 1.22 (0.89–1.7) | 1.46 (1.02–2.04) |
| Apolipoprotein A1, g/L | 1.14 ± 0.19 | 1.11 ± 0.18 | 1.21 ± 0.17 |
| Apolipoprotein B, g/L | 0.72 (0.59–0.88) | 0.72 (0.59–0.87) | 0.75 (0.62–0.93) |
| hs-CRP, mg/L | 1.43 (0.57–3.95) | 1.61 (0.59–4.05) | 1.12 (0.53–3.57) |
| Uric acid, μmol/L | 320 (273–373) | 334 (286–382) | 291 (255–358) |
| Culprit coronary artery, % | |||
| Left anterior descending, % | 531 (82.5) | 358 (83.1) | 173 (82.1) |
| Left circumflex, % | 275 (42.7) | 190 (44.1) | 85 (39.9) |
| Right, % | 315 (48.9) | 221 (51.4) | 94 (44.1) |
| Left main, % | 47 (7.3) | 34 (7.9) | 13 (6.1) |
| Diseased vessels | |||
| One-vessel disease, % | 292 (45.3) | 180 (41.8) | 112 (52.6) |
| Two-vessel disease, % | 227 (35.2) | 164 (38.1) | 63 (29.6) |
| Three-vessel disease, % | 125 (19.4) | 87 (20.2) | 38 (17.8) |
| Lesion morphology | |||
| Diffuse lesion, % | 112 (17.4) | 84 (19.5) | 28 (13.2) |
| Calcification lesion, % | 72 (11.2) | 59 (13.7) | 13 (6.1) |
| Total occlusion lesion, % | 79 (12.3) | 59 (13.7) | 20 (9.4) |
| Complex lesion (Types B and C), % | 234 (36.3) | 187 (43.4) | 47 (20.4) |
| Gensini score | 38(15–66) | 42(20–71) | 29(8–54) |
Abbreviations: LDL-C, low-density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; hs-CRP, high sensitive C reactive protein.
Anthropometric and Cardiovascular Risk Factors in Male and Female Subjects with a Normal Body Mass Index by Waist Circumference Tertiles
| Characteristic | Tertiles of Waist Circumference | ||||
|---|---|---|---|---|---|
| Tertile 1 | Tertile 2 | Tertile 3 | |||
| 140 (32.5) | 143 (33.2) | 148 (34.3) | |||
| WC (cm) | 83.0 (78.0–86.0) | 89.5 (89.0–91.0) | 96.0 (94.0–98.0) | ||
| BMI kg/m2 | 21.7 ± 1.55 | 23.1 ± 1.08* | 23.5 ± 0.67*,# | <0.001 | <0.001 |
| Height (cm) | 169.0 ± 4.94 | 171.0 ± 5.31* | 174.0 ± 5.22*,# | <0.001 | <0.001 |
| Weight (kg) | 62.01 ± 5.28 | 68.05 ± 5.18* | 71.41 ± 5.55*,# | <0.001 | <0.001 |
| HC (cm) | 87.0 ± 4.52 | 91.8 ± 3.23* | 95.1 ± 3.75*,# | <0.001 | <0.001 |
| WHR | 0.93 ± 0.05 | 0.98 ± 0.03* | 1.02 ± 0.04*,# | <0.001 | <0.001 |
| Age (years) | 62.1 ± 8.88 | 60.3 ± 8.88 | 60.2 ± 9.90 | 0.146 | 0.084 |
| Family history of CAD, % | 22 (15.7) | 37 (25.9) | 35 (23.7) | 0.094 | 0.109 |
| Ever smokers, % | 74 (52.9) | 73 (51.0) | 65 (43.9) | 0.273 | 0.128 |
| Diabetes, % | 41 (29.3) | 61 (42.6)* | 64 (43.2)* | 0.024 | 0.022 |
| Hypertension, % | 63 (45.0) | 73 (51.0) | 83 (56.1) | 0.170 | 0.061 |
| Dyslipidemia, % | 82 (58.6) | 121 (84.6)* | 126 (85.1)* | <0.001 | <0.001 |
| Apo B/A1, g/L | 0.64 ± 0.21 | 0.69 ± 0.21* | 0.70 ± 0.26* | 0.023 | 0.010 |
| hs-CRP, mg/L | 1.01 (0.45–2.48) | 1.48 (0.60–4.65)* | 2.51 (0.87–4.98)* | <0.001 | <0.001 |
| Uric acid, μmol/L | 315 (264–369) | 327 (284–378) | 349 (304–389)*, # | 0.001 | 0.001 |
| Triglycerides-glucose index | 8.6 ± 0.57 | 8.9 ± 0.64* | 8.9 ± 0.65* | <0.001 | 0.001 |
| 65 (30.5) | 69 (32.4) | 79 (37.1) | |||
| WC (cm) | 78.5 (77.5–79.3) | 84.0 (82.0–84.5) | 90.0 (88.0–91.0) | ||
| BMI kg/m2 | 21.51 ± 1.73 | 22.66 ± 1.21* | 23.40 ± 0.59*,# | <0.001 | <0.001 |
| Height (cm) | 158.2 ± 4.92 | 159.2 ± 5.63 | 160.7 ± 5.48* | 0.025 | 0.007 |
| Weight (kg) | 53.95 ± 5.91 | 57.43 ± 4.43* | 60.47 ± 4.41*,# | 0.002 | <0.001 |
| HC (cm) | 89.5 ± 5.20 | 93.8 ± 3.22* | 97.9 ± 4.35*,# | <0.001 | <0.001 |
| WHR | 0.88 ± 0.05 | 0.91 ± 0.04* | 0.94 ± 0.04*,# | <0.001 | <0.001 |
| Age (years) | 62.4 ± 9.48 | 62.8 ± 8.56 | 65.2 ± 7.69 | 0.113 | 0.059 |
| Family history of CAD, % | 27 (41.5) | 15 (41.7) | 27 (34.2)* | 0.046 | 0.419 |
| Diabetes, % | 30 (46.2) | 33 (47.8) | 33 (41.8) | 0.745 | 0.579 |
| Hypertension, % | 34 (52.3) | 43 (62.3) | 38 (48.1) | 0.212 | 0.551 |
| Dyslipidemia, % | 53 (84.6) | 63 (91.3) | 76 (96.2) | 0.052 | 0.016 |
| Apo B/ A1, g/L | 0.62 ± 0.19 | 0.68 ± 0.20 | 0.66 ± 0.19 | 0.258 | 0.308 |
| hs-CRP, mg/L | 0.89 (0.51–3.42) | 1.12 (0.56–3.94) | 1.48 (0.52–4.47) | 0.710 | 0.374 |
| Uric acid, μmol/L | 275 (245–328) | 292 (267–350)* | 302 (266–364)*, # | 0.025 | 0.006 |
| Triglycerides-glucose index | 9.6 ± 0.73 | 9.8 ± 0.71 | 9.7 ± 0.75 | 0.111 | 0.156 |
Notes: *p <0.05 vs Tertile 1; #p < 0.05 vs Tertile 2.
Abbreviations: WC, waist circumference; BMI, body mass index; HC, hip circumference; WHR, waist to hip ratio; Apo B/A1, apolipoprotein B/apolipoprotein A1; hs-CRP, high sensitive C reactive protein.
Angiographic Characteristics in Male and Female Subjects with a Normal Body Mass Index by Waist Circumference Tertiles
| Characteristic | Tertiles of Waist Circumference | ||||
|---|---|---|---|---|---|
| Tertile 1 | Tertile 2 | Tertile 3 | |||
| 140 (32.5) | 143 (33.2) | 148 (34.3) | |||
| Culprit coronary artery, % | |||||
| Left anterior descending, % | 113 (80.7) | 121 (84.6) | 124 (83.8) | 0.654 | 0.494 |
| Left circumflex, % | 59 (42.1) | 59 (41.2) | 72 (48.7) | 0.381 | 0.261 |
| Right, % | 66 (47.1) | 73 (51.4) | 82 (55.4) | 0.374 | 0.161 |
| Left main, % | 6 (4.3) | 10 (7.0)* | 18 (12.2)*,# | 0.041 | 0.013 |
| Diseased vessels, % | |||||
| One vessel disease, % | 63 (45.0) | 56 (39.2) | 61 (41.2) | 0.601 | 0.524 |
| Two vessel disease, % | 56 (40.0) | 64 (44.8)* | 44 (29.7)*,# | 0.026 | 0.068 |
| Three vessel disease, % | 21 (15.0) | 23 (16.1) | 43 (29.1)*,# | 0.004 | 0.003 |
| Lesion morphology, % | |||||
| Diffuse lesion, % | 22 (15.7) | 32 (22.4) | 30 (20.3) | 0.352 | 0.338 |
| Calcification lesion, % | 9 (6.4) | 23 (16.1)* | 27 (18.2)* | 0.010 | 0.006 |
| Total occlusion lesion, % | 5 (3.6) | 18 (12.6)* | 36 (24.3)*, # | <0.001 | <0.001 |
| Complex lesion (Types B and C), % | 36 (25.7) | 65 (45.5)* | 86 (58.1)*,# | 0.001 | <0.001 |
| Gensini score | 39(18–57) | 45(20–71) | 48(20–104)* | 0.021 | <0.001 |
| 65 (30.5) | 69 (32.4) | 79 (37.1) | |||
| Culprit coronary artery, % | |||||
| Left anterior descending, % | 51 (78.5) | 57 (82.6) | 65 (82.3) | 0.791 | 0.578 |
| Left circumflex, % | 23 (35.4) | 26 (37.7) | 36 (45.6) | 0.461 | 0.416 |
| Right, % | 26 (40.0) | 28 (40.6) | 40 (50.6) | 0.34 | 0.189 |
| Left main, % | 1 (1.5) | 6 (8.7) | 6 (7.6) | 0.176 | 0.149 |
| Diseased vessels, % | |||||
| One vessel disease, % | 35 (53.9) | 40 (58.0) | 37 (46.8) | 0.388 | 0.370 |
| Two vessel disease, % | 25 (14.0) | 16 (25.0) | 22 (16.8) | 0.14 | 0.192 |
| Three vessel disease, % | 5 (7.7) | 13 (18.8)* | 20 (25.3)*,# | 0.02 | 0.006 |
| Lesion morphology, % | |||||
| Diffuse lesion, % | 3 (4.6) | 11 (15.9)* | 14 (17.7)* | 0.048 | 0.024 |
| Calcification lesion, % | 1 (1.5) | 7 (10.1) | 5 (6.3) | 0.114 | 0.273 |
| Total occlusion lesion, % | 5 (7.7) | 5 (7.3) | 10 (12.7) | 0.453 | 0.292 |
| Complex lesion (Types B and C), % | 8 (12.3) | 16 (23.2)* | 23 (29.1)*,# | 0.043 | 0.017 |
| Gensini score | 32(9–55) | 27(8–51) | 27(6–54) | 0.897 | 0.581 |
Notes: *p <0.05 vs Tertile 1; #p < 0.05 vs Tertile 2.
Severe CAD in Male and Female Subjects with a Normal Body Mass Index by Waist Circumference Tertiles
| WC Levels | Unadjusted | Adjusteda |
|---|---|---|
| OR (95% CI) | OR (95% CI) | |
| Tertile 1 | 1.00 (reference) | 1.00 (reference) |
| Tertile 2 | 1.42 (0.86–2.32) | 1.20 (0.70–2.06) |
| Tertile 3 | 2.21 (1.36–3.59) | 1.87 (1.09–3.20) |
| Tertile 1 | 1.00 (reference) | 1.00 (reference) |
| Tertile 2 | 0.74 (0.36–1.55) | 0.82 (0.39–1.73) |
| Tertile 3 | 1.20 (0.60–2.38) | 0.57 (0.27–1.20) |
Notes: aAdjusted for cardiovascular risk factors (age, smoking status, family history of CAD, hypertension, diabetes dyslipidemia, Apo B/A1, hs-CRP, uric acid and triglycerides–glucose index).
Figure 1Kaplan–Meier curves showing the cumulative risk of one-year re-admission with adverse cardiovascular events after discharge in (A) male and (B) female subjects with a normal body mass index by waist circumference tertiles.
One-Year Re-Admission with Adverse Cardiovascular Events After Discharge in Male and Female Subjects with a Normal Body Mass Index by Waist Circumference Tertiles
| WC Levels | Unadjusted | Adjusted | ||
|---|---|---|---|---|
| Model 1 | Model 2 | Model 3 | ||
| Tertile 1 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
| Tertile 2 | 1.64 (0.82–3.27) | 1.31 (0.64–2.70) | 1.39 (0.68–2.85) | 1.47 (0.67 −3.21) |
| Tertile 3 | 2.54 (1.33–4.83) | 2.13 (1.06–4.27) | 2.16 (1.08–4.31) | 2.33 (1.04–5.21) |
| Tertile 1 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
| Tertile 2 | 1.36 (0.43–4.30) | 1.36 (0.41–4.56) | 1.57 (0.41–6.06) | 1.82 (0.39–8.49) |
| Tertile 3 | 1.47 (0.48–4.48) | 1.54 (0.46–5.14) | 2.25 (0.60–8.49) | 2.79 (0.52–15.06) |
Notes: The data are reported as HR (95% CI). Model 1: adjusted for cardiovascular risk factors (age, smoking status, family history of CAD, hypertension, diabetes dyslipidemia, Apo B/A1, hs-CRP, uric acid, and triglycerides-glucose index). Model 2: adjusted for variables in Model 1 plus menopause status, length of stay, and patient compliance. Model 3: adjusted for variables in Model 2 plus BMI (kg/m2).